A carregar...
Nanomedicines in the treatment of acromegaly: focus on pegvisomant
This article examines the role of pegvisomant in the treatment of acromegaly. This syndrome, caused by excessive growth hormone (GH) secretion by a pituitary adenoma, is associated with a doubled mortality rate and poor quality of life. Pituitary microsurgery has long been the first choice of treatm...
Na minha lista:
Main Authors: | , , , |
---|---|
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2006
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2676637/ https://ncbi.nlm.nih.gov/pubmed/17722273 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|